Coupling/NN
of/IN
a/DT
signal/NN
response/NN
domain/NN
in/IN
I/NN
kappa/NN
B/NN
alpha/NN
to/TO
multiple/JJ
pathways/NNS
for/IN
NF-kappa/NN
B/NN
activation/NN
./.

The/DT
eukaryotic/JJ
transcription/NN
factor/NN
NF-kappa/NN
B/NN
plays/VBZ
a/DT
central/JJ
role/NN
in/IN
the/DT
induced/VBN
expression/NN
of/IN
human/JJ
immunodeficiency/NN
virus/NN
type/NN
1/CD
and/CC
in/IN
many/JJ
aspects/NNS
of/IN
the/DT
genetic/JJ
program/NN
mediating/VBG
normal/JJ
T-cell/NN
activation/NN
and/CC
growth/NN
./.
=====
The/DT
nuclear/JJ
activity/NN
of/IN
NF-kappa/NN
B/NN
is/VBZ
tightly/RB
regulated/VBN
from/IN
the/DT
cytoplasmic/JJ
compartment/NN
by/IN
an/DT
inhibitory/JJ
subunit/NN
called/VBN
I/NN
kappa/NN
B/NN
alpha/NN
./.
=====
This/DT
cytoplasmic/JJ
inhibitor/NN
is/VBZ
rapidly/RB
phosphorylated/VBN
and/CC
degraded/VBN
in/IN
response/NN
to/TO
a/DT
diverse/JJ
set/NN
of/IN
NF-kappa/NN
B-inducing/JJ
agents/NNS
,/,
including/VBG
T-cell/NN
mitogens/NNS
,/,
proinflammatory/JJ
cytokines/NNS
,/,
and/CC
viral/JJ
transactivators/NNS
such/JJ
as/IN
the/DT
Tax/NN
protein/NN
of/IN
human/JJ
T-cell/NN
leukemia/NN
virus/NN
type/NN
1/CD
./.
=====
To/TO
explore/VB
these/DT
I/NN
kappa/NN
B/NN
alpha-dependent/JJ
mechanisms/NNS
for/IN
NF-kappa/NN
B/NN
induction/NN
,/,
we/PRP
identified/VBD
novel/JJ
mutants/NNS
of/IN
I/NN
kappa/NN
B/NN
alpha/NN
that/WDT
uncouple/VBP
its/PRP$
inhibitory/JJ
and/CC
signal-transducing/JJ
functions/NNS
in/IN
human/JJ
T/NN
lymphocytes/NNS
./.
=====
Specifically/RB
,/,
removal/NN
of/IN
the/DT
N-terminal/JJ
36/CD
amino/NN
acids/NNS
of/IN
I/NN
kappa/NN
B/NN
alpha/NN
failed/VBD
to/TO
disrupt/VB
its/PRP$
ability/NN
to/TO
form/VB
latent/JJ
complexes/NNS
with/IN
NF-kappa/NN
B/NN
in/IN
the/DT
cytoplasm/NN
./.
=====
However/RB
,/,
this/DT
deletion/NN
mutation/NN
prevented/VBD
the/DT
induced/VBN
phosphorylation/NN
,/,
degradative/JJ
loss/NN
,/,
and/CC
functional/JJ
release/NN
of/IN
I/NN
kappa/NN
B/NN
alpha/NN
from/IN
NF-kappa/NN
B/NN
in/IN
Tax-expressing/JJ
cells/NNS
./.
=====
Alanine/NN
substitutions/NNS
introduced/VBN
at/IN
two/CD
serine/NN
residues/NNS
positioned/JJ
within/IN
this/DT
N-terminal/JJ
regulatory/JJ
region/NN
of/IN
I/NN
kappa/NN
B/NN
alpha/NN
also/RB
yielded/VBD
constitutive/JJ
repressors/NNS
that/WDT
escaped/VBD
from/IN
Tax-induced/JJ
turnover/NN
and/CC
that/WDT
potently/RB
inhibited/VBD
immune/JJ
activation/NN
pathways/NNS
for/IN
NF-kappa/NN
B/NN
induction/NN
,/,
including/VBG
those/DT
initiated/VBN
from/IN
antigen/NN
and/CC
cytokine/NN
receptors/NNS
./.
=====
In/IN
contrast/NN
,/,
introduction/NN
of/IN
a/DT
phosphoserine/NN
mimetic/JJ
at/IN
these/DT
sites/NNS
rectified/VBD
this/DT
functional/JJ
defect/NN
,/,
a/DT
finding/NN
consistent/JJ
with/IN
a/DT
causal/JJ
linkage/NN
between/IN
the/DT
phosphorylation/NN
status/NN
and/CC
proteolytic/JJ
stability/NN
of/IN
this/DT
cytoplasmic/JJ
inhibitor/NN
./.
=====
Together/RB
,/,
these/DT
in/FW
vivo/FW
studies/NNS
define/VBP
a/DT
critical/JJ
signal/NN
response/NN
domain/NN
in/IN
I/NN
kappa/NN
B/NN
alpha/NN
that/WDT
coordinately/RB
controls/VBZ
the/DT
biologic/JJ
activities/NNS
of/IN
I/NN
kappa/NN
B/NN
alpha/NN
and/CC
NF-kappa/NN
B/NN
in/IN
response/NN
to/TO
viral/JJ
and/CC
immune/JJ
stimuli/NNS
./.